11 patents
Utility
Compositions and Methods for Treatment of Cytomegalovirus
31 Aug 23
The present disclosure provides compositions and methods useful for treating HCMV infection.
David E. Anderson, Anne-Catherine Fluckiger
Filed: 11 Feb 22
Utility
Vaccines, Adjuvants, and Methods of Generating an Immune Response
18 May 23
Provided herein are vaccines including coronavirus antigens and E6020, as well as methods of mitigation of coronavirus infection by administering those vaccines.
Fabian GUSOVSKY, Lynn HAWKINS, Sally ISHIZAKA, David Evander ANDERSON, Anne-Catherine FLUCKIGER
Filed: 6 Apr 21
Utility
Immunogenic Compositions for Treatment of Hepatitis B
16 Mar 23
The present disclosure provides compositions and methods useful for inducing a The cell response in a subject suffering from Hepatitis B.
David Evander ANDERSON, Tanvir AHMED
Filed: 13 Nov 19
Utility
Immunotherapeutic Compositions
26 Jan 23
The present disclosure provides compositions and methods useful for treating Glioblastoma Multiforme (GBM) which comprise virus-like particles (VLPs) comprising murine leukemia virus (MLV) core proteins and the human cytomegalovirus epitopes, gB and pp65, formulated with an adjuvant comprising a saponin and a TLR4 agonist.
Kirsten SCHNEIDER-OHRUM, David Evander ANDERSON
Filed: 8 Sep 22
Utility
Vaccine Compositions for the Treatment of Coronavirus
28 Jul 22
The present disclosure provides compositions and methods useful for preventing and/or treating coronavirus infection.
David Evander Anderson, Anne-Catherine Fluckiger
Filed: 12 Jan 22
Utility
Vaccine compositions for the treatment of coronavirus
22 Feb 22
The present disclosure provides compositions and methods useful for preventing and/or treating coronavirus infection.
David Evander Anderson, Anne-Catherine Fluckiger
Filed: 30 Mar 21
Utility
Compositions and methods for treatment of cytomegalovirus
15 Feb 22
The present disclosure provides compositions and methods useful for treating HCMV infection.
David E. Anderson, Anne-Catherine Fluckiger, David Klatzmann, Charlotte Dalba-Fribert
Filed: 22 Aug 17
Utility
Vaccine Compositions for the Treatment of Coronavirus
18 Nov 21
The present disclosure provides compositions and methods useful for preventing and/or treating coronavirus infection.
David Evander Anderson, Anne-Catherine Fluckiger
Filed: 30 Mar 21
Utility
Methods and compositions for therapeutic agents
9 Nov 21
The present disclosure provides inter alia compositions that comprise therapeutic agents (e.g., live attenuated viral antigens, therapeutic proteins, etc.) and a lipid component.
Marc J. Kirchmeier, David E. Anderson
Filed: 18 Apr 18
Utility
Compositions and methods for treating viral infections
9 Nov 21
The present disclosure provides compositions and methods useful for treating viral infections.
David E. Anderson
Filed: 13 Nov 17
Utility
Immunotherapeutic Compositions
11 Mar 21
The present disclosure provides compositions and methods useful for treating Glioblastoma Multiforme (GBM) which comprise virus-like particles (VLPs) comprising murine leukemia virus (MLV) core proteins and the human cytomegalovirus epitopes, gB and pp65, formulated with an adjuvant comprising a saponin and a TLR4 agonist.
Kirsten SCHNEIDER-OHRUM, David Evander ANDERSON
Filed: 8 Sep 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first